Patents by Inventor Klaus Muhlegger

Klaus Muhlegger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8013147
    Abstract: The invention concerns compounds of the general formula (I) in which the residues R1 to R7 have the meanings given in the application as well as methods for their preparation. The compounds are in particular suitable as substrates for RNA or DNA polymerases and can thus be incorporated into RNA or DNA oligonucleotides and are especially suitable for labelling and detecting nucleic acids or for DNA sequencing.
    Type: Grant
    Filed: March 2, 2005
    Date of Patent: September 6, 2011
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Klaus Muhlegger, Herbert Von Der Eltz
  • Publication number: 20050222056
    Abstract: The invention concerns compounds of the general formula (I) in which the residues R1 to R7 have the meanings given in the application as well as methods for their preparation. The compounds are in particular suitable as substrates for RNA or DNA polymerases and can thus be incorporated into RNA or DNA oligonucleotides and are especially suitable for labelling and detecting nucleic acids or for DNA sequencing.
    Type: Application
    Filed: March 2, 2005
    Publication date: October 6, 2005
    Inventors: Klaus Muhlegger, Herbert Von Der Eltz
  • Patent number: 6916616
    Abstract: The invention concerns stable aqueous solutions containing one or several nucleoside triphosphates wherein the respective solution has a pH value of more than 7.5 and contains no additional substances with a stabilizing effect. The nucleoside triphosphate solutions are used in particular for DNA synthesizing reactions such as e.g. RT-PCR, cycle sequencing, random priming and nick translation. One of the most important applications of such solutions containing deoxy-nucleoside triphosphates (d-NTP) is their use in the polymerase chain reaction (PCR).
    Type: Grant
    Filed: December 19, 2001
    Date of Patent: July 12, 2005
    Assignee: Roche Diagnostics GmbH
    Inventors: Hans-Georg Ihlenfeldt, Axel Schmidt, Klaus Muhlegger, Volker Leitenberger
  • Patent number: 6875859
    Abstract: The invention concerns compounds of the general formula (I) in which the residues R1 to R7 have the meanings given in the application as well as methods for their preparation.
    Type: Grant
    Filed: March 11, 2002
    Date of Patent: April 5, 2005
    Assignee: Roche Diagnostics GmbH
    Inventors: Klaus Mühlegger, Herbert Von Der Eltz
  • Patent number: 6498241
    Abstract: 2′-Deoxyisoguanosine, isosteric analogues and isoguanosine derivatives of formulae I-V, processes for their production via compounds of the general formulae a or b and reaction with aroyl isocyanates or from compounds of the general formulae VI-IX by photochemical irradiation. A further production process is the conversion of deoxyguanosines or guanosines by means of persilylation, reaction with ammonia and deamination in the 2 position. The compounds are suitable as pharmaceutical agents with antiviral efficacy.
    Type: Grant
    Filed: November 13, 2000
    Date of Patent: December 24, 2002
    Assignee: Roche Diagnostics GmbH
    Inventors: Frank Seela, Zigmunt Kasimierczuk, Klaus Mühlegger, Herbert Von Der Eltz
  • Publication number: 20020119534
    Abstract: The invention concerns stable aqueous solutions containing one or several nucleoside triphosphates wherein the respective solution has a pH value of more than 7.5 and contains no additional substances with a stabilizing effect. The nucleoside triphosphate solutions are used in particular for DNA synthesizing reactions such as e.g. RT-PCR, cycle sequencing, random priming and nick translation. One of the most important applications of such solutions containing deoxy-nucleoside triphosphates (d-NTP) is their use in the polymerase chain reaction (PCR).
    Type: Application
    Filed: December 19, 2001
    Publication date: August 29, 2002
    Inventors: Hans-Georg Ihlenfeldt, Axel Schmidt, Klaus Muhlegger, Volker Leitenberger
  • Publication number: 20020099202
    Abstract: The invention concerns compounds of the general formula (I) in which the residues R1 to R7 have the meanings given in the application as well as methods for their preparation. The compounds are in particular suitable as substrates for RNA or DNA polymerases and can thus be incorporated into RNA or DNA oligonucleotides and are especially suitable for labelling and detecting nucleic acids or for DNA sequencing.
    Type: Application
    Filed: March 11, 2002
    Publication date: July 25, 2002
    Applicant: Roche Molecular Systems, Inc.
    Inventors: Klaus Muhlegger, Herbert Von Der Eltz
  • Patent number: 6403786
    Abstract: The invention concerns compounds of the general formula (I) in which i:he residues R1 to R7 have the meanings given in the application as well as methods for their preparation. The compounds are in particular suitable as substrates for RNA or DNA polymerases and can thus be incorporated into RNA or DNA oligonucleotides and are especially suitable for labelling and detecting nucleic acids or for DNA sequencing.
    Type: Grant
    Filed: July 2, 1999
    Date of Patent: June 11, 2002
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Klaus Mühlegger, Herbert Von der Eltz
  • Publication number: 20020004230
    Abstract: The invention concerns stable aqueous solutions containing one or several nucleoside triphosphates wherein the respective solution has a pH value of more than 7.5 and contains no additional substances with a stabilizing effect. The nucleoside triphosphate solutions are used in particular for DNA synthesizing reactions such as e.g. RT-PCR, cycle sequencing, random priming and nick translation. One of the most important applications of such solutions containing deoxynucleoside triphosphates (d-NTP) is their use in the polymerase chain reaction (PCR).
    Type: Application
    Filed: November 19, 1999
    Publication date: January 10, 2002
    Inventors: HANS-GEORG IHLENFELDT, AXEL SCHMIDT, KLAUS MUHLEGGER, VOLKER LEITENBERGER
  • Patent number: 6320035
    Abstract: The invention concerns pyrrolo-[3,2-d]pyrimidine, pyrazolo-[4,3-d]pyrimidine and pyrimidine-furanosides i.e. so-called C-nucleosides of the general formulae I-V or appropriate derivatives as well as processes for their production.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: November 20, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Klaus Mühlegger, Herbert Von Der Eltz, Frank Seela, Helmet Rosemeyer
  • Patent number: 6211158
    Abstract: The present invention provides desazapurine-nucleoside derivatives of the general formula: wherein X is a nitrogen atom or a methine radical, W is a nitrogen atom or a C—R4 radical, R1, R2, R3 and R4, which can be the same or different, are hydrogen or halogen atoms, hydroxyl or mercapto groups, lower alkyl, lower alkylthio, lower alkoxy, aralkyl, aralkoxy or aryloxy radicals or amino groups optionally substituted once or twice, R5 is a hydrogen atom or a hydroxyl group, R6 and R7 are each hydrogen atoms or one of them is a halogen atom or a cyano or azido group or an amino group optionally substituted once or twice, whereby one of R6 and R7 can also be a hydroxyl group when X is a methine radical and, in addition, R5 and R7 can together also represent a further valency bond between C-2′ and C-3′ and Y is a hydrogen atom or a mono-, di- or tri-phosphate group.
    Type: Grant
    Filed: June 26, 1992
    Date of Patent: April 3, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Frank Seela, Heinz-Peter Muth, Klaus Kaiser, Werner Bourgeois, Klaus Mühlegger, Herbert Von der Eltz, Hans-Georg Batz
  • Patent number: 6184379
    Abstract: The invention concerns rhodamine derivatives of the general formulae in which Ca-Cd each denote a C atom, and Ca and Cb as well as Cc and Cd are either linked together by a single bond or by a double bond; X1 to X16 denote independently of one another halogen, sulfonic acid, hydrogen or an alkyl residue with 1-20 C atoms in which the alkyl residue can be substituted with one or several halogen or sulfonic acid residues; R1 and R2 are either identical or different and denote either hydrogen, alkyl with 1-20 C atoms, polyoxyhydrocarbyl units, phenyl or phenylalkyl with 1-3 carbon atoms in the alkyl chain in which the alkyl and/or phenyl residues can be substituted by one or several hydroxy, halogen, sulfonic acid, amino, carboxy or alkoxycarbonyl groups where alkoxy can have 1-4 carbon atoms, R1 contains at least one activatable group, R2 and X4 can be optionally linked together via a bridge composed of 0-2 C atoms.
    Type: Grant
    Filed: June 2, 1999
    Date of Patent: February 6, 2001
    Assignee: Roche Diagnostics GmbH
    Inventors: Hans-Peter Josel, Rupert Herrmann, Dieter Heindl, Klaus Muhlegger, Gregor Sagner, Karl Heinz Drexhage, Jorg Frantzeskos, Jutta Arden-Jacob
  • Patent number: 6147199
    Abstract: 2'-Deoxyisoguanosine, isosteric analogues and isoguanosine derivatives of formulae I-V, processes for their production via compounds of the general formulae a or b and reaction with aroyl isocyanates or from compounds of the general formulae VI-IX by photochemical irradiation. A further production process is the conversion of deoxyguanosines or guanosines by means of persilylation, reaction with ammonia and deamination in the 2 position. The compounds are suitable as pharmaceutical agents with antiviral efficacy.
    Type: Grant
    Filed: May 29, 1998
    Date of Patent: November 14, 2000
    Assignee: Boehringer Mannheim
    Inventors: Frank Seela, Zigmunt Kasimierczuk, Klaus Muhlegger, Herbert Von Der Eltz
  • Patent number: 5902878
    Abstract: The subject matter of the invention is a modified phosphoramidite process for the synthesis of nucleotide sequences. By use of a modified nucleoside phosphoramidite it is possible to produce nucleotide sequences which have a modified phosphate residue.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: May 11, 1999
    Assignee: Boehringer Mannheim GmbH
    Inventors: Heinz-Hartmut Seliger, Sibylle Berner, Klaus Muhlegger, Herbert Von Der Eltz, Hans-Georg Batz
  • Patent number: 5700919
    Abstract: The subject matter of the invention is a modified phosphoramidite process for the synthesis of nucleotide sequences. By use of a modified nucleoside phosphoramidite it is possible to produce nucleotide sequences which have a modified phosphate residue.
    Type: Grant
    Filed: January 10, 1995
    Date of Patent: December 23, 1997
    Assignee: Boehringer Mannhiem GmbH
    Inventors: Heinz-Hartmut Seliger, Sibylle Berner, Klaus Muhlegger, Herbert Von der Eltz, Hans-Georg Batz
  • Patent number: 5198537
    Abstract: The present invention provides digoxigenin derivatives of the formula: ##STR1## wherein n is a whole number of from 1 to 4 and Z is a carboxyl group or a functional derivative derived therefrom. The present invention also provides digoxigenin conjugates of the general formula: ##STR2## wherein the carrier is an immunogenic carrier material, a nucleic acid or a labelled immunocomponent of a labelled digoxigenin immunoconjugate for use in an immunoassay, m is a number from 1 to the number of coupling positions available on the carrier and Y is the group formed by the reaction of the carboxyl function Z of the digoxigenin derivative of general formula (I) with the reacting position of the carrier material. Also described are uses of these conjugates as nucleic acid probes, immunogens, and in immunoassay.
    Type: Grant
    Filed: October 25, 1989
    Date of Patent: March 30, 1993
    Assignee: Boehringer Mannheim GmbH
    Inventors: Erasmus Huber, Klaus Muhlegger, Herbert von der Eltz, Bruno Zink
  • Patent number: 5035998
    Abstract: Reagents for the determination of hydrolase comprises compounds of the formula ##STR1## wherein Z is an organic or inorganic acid residue or a sugar residue, A is an organic or inorganic acid residue, and B is an organic acid residue. Each of R.sup.2 and R.sup.5, is hydrogen, halogen or lower alkyl. Each of R.sup.1, R.sup.3, R.sup.4 and R.sup.6, is hydrogen, halogen, cyano, lower alkyl, lower alkoxy, carboxyl, lower alkoxycarbonyl, carboxy lower alkyl or lower alkoxycarbonyl lower alkyl, or carboxamido groups optical substituted once or twice, or a radical of the formula--COO--(CH.sub.2 CH.sub.2 O).sub.n --R.sup.7in which R.sup.7 is hydrogen or lower alkyl and n is a number from 1 to 4. Additionally, R.sup.6 can be sulpho or nitro.
    Type: Grant
    Filed: November 13, 1989
    Date of Patent: July 30, 1991
    Assignee: Boehringer Mannheim GmbH
    Inventors: Herbert von der Eltz, Hans-Joachim Guder, Klaus Muhlegger
  • Patent number: 4900822
    Abstract: Reagents for the determination of hydrolase comprises compounds of the formula ##STR1## wherein Z is an organic or inorganic acid residue or a sugar residue, A is an organic or inorganic acid residue, and B is an organic acid residue. Each of R.sup.2 and R.sup.5, is hydrogen, halogen or lower alkyl. Each of R.sup.1, R.sup.3, R.sup.4 and R.sup.6, is hydrogen, halogen, cyano, lower alkyl, lower alkoxy, carboxyl, lower alkoxycarbonyl, carboxy lower alkyl or lower alkoxycarbonyl lower alkyl, or carboxamido groups optional substituted once or twice, or a radical of the formula--COO--(CH.sub.2 CH.sub.2 O).sub.n --R.sup.7in which R.sup.7 is hydrogen or lower alkyl and n is a number from 1 to 4. Additionally, R.sup.6 can be sulpho or nitro.
    Type: Grant
    Filed: December 21, 1987
    Date of Patent: February 13, 1990
    Assignee: Boehringer Mannheim GmbH
    Inventors: Herbert von der Eltz, Hans-Joachim Guder, Klaus Muhlegger
  • Patent number: 4719097
    Abstract: The present invention provides phosphates of resorufin derivatives of the general formulae: ##STR1## wherein R.sup.2 and R.sup.5, which can be the same or different, are hydrogen or halogen atoms or lower alkyl radicals, R.sup.1, R.sup.3, R.sup.4 and R.sup.6, which can be the same or different, are hydrogen or halogen atoms, cyano or carboxy groups or lower alkyl, lower alkoxy, lower alkoxycarbonyl, carboxy lower alkyl or lower alkoxycarbonyl lower alkyl radicals or carboxamide groups which are optionally mono- or disubstituted or radicals of the general formula --COO--(CH.sub.2 CH.sub.2 O).sub.n --R.sup.7, R.sup.7 being a hydrogen atom or a lower alkyl radical and n being a whole number of from 1 to 4, and wherein R.sup.6 can additionally also be a sulphonyl or nitro group, Y is a nitrogen atom or an N.fwdarw.O group and M and M', which can be the same or different, are hydrogen atoms or alkali metal, alkaline earth metal or ammonium ions.
    Type: Grant
    Filed: September 26, 1986
    Date of Patent: January 12, 1988
    Assignee: Boehringer Mannheim GmbH
    Inventors: Klaus Muhlegger, Herbert von der Eltz
  • Patent number: 4148994
    Abstract: Crystalline salts of .beta.-nicotinamide-adenine-dinucleotide (.beta.-NAD), particularly alkali metal salts thereof are prepared in good yield and high quality to provide an analytically useful .beta.-NAD form.
    Type: Grant
    Filed: December 27, 1976
    Date of Patent: April 10, 1979
    Assignee: Boehringer Mannheim GmbH
    Inventors: Klaus Muhlegger, Gunter Weimann, Michael Nelboeck-Hochstetter